Aid by Sector
South Sudan Health Pooled Fund Phase III
UK - Foreign, Commonwealth Development Office (FCDO)
To provide a government led effective health system that will deliver improved access to quality health services across seven states in South Sudan with a specific focus on reducing maternal and child mortality. The Health Pooled Fund (HPF3) will reduce maternal and under-five mortality rates in South Sudan, through (i) the delivery of a basic package of health and nutrition services; (ii) promoting community engagement in health as a public good and (iii) supporting local health systems stabilisation.
LAFIYA -UK Support for Health in Nigeria
UK - Foreign, Commonwealth Development Office (FCDO)
To save lives, reduce suffering and improve economic prospects for the poorest and most vulnerable in Nigeria through: i. Encouraging Government of Nigeria to increase resources invested in health (through advocacy, community accountability; and data to inform government prioritisation using a “delivery” approach, as used successfully in Pakistan) ii. Improving effectiveness and efficiency of public and private basic health services (through innovative financing mechanisms, strengthening health systems and working with private sector to deliver affordable health services for the poorest populations) iii. Reducing total fertility rate (through addressing social norms, demographic impact analysis, and support to family planning commodities and services).
Essential Services for Maternal and Child Health [Services Essentiels de Santé Maternelle et Infantile en RDC (SEMI)]
UK - Foreign, Commonwealth Development Office (FCDO)
To support essential maternal, child and infant health services to end preventable deaths in one of the poorest provinces in DRC and strengthen the health system at national and provincial level.
Umoyo Wathu Health System Strengthening Programme
UK - Foreign, Commonwealth Development Office (FCDO)
To reduce rates and inequalities in maternal, under-5 and new-born deaths; as well as reduce stunting in under-5s, by strengthening the quality and coverage of a package of essential health services through lower level district administration. The programme will increase the provision and uptake of quality, highly cost effective life-saving primary healthcare services provided free at the point of use, and so better protect the most vulnerable against the financial consequences of ill health. By 2028, the programme will contribute to reducing maternal mortality from 439 to 350 per 100,000 births; neonatal mortality from 27 to 22 per 1,000 live births; child mortality from 64 to 48 per 1,000 live births; stunting in children under five years of age reduced from 37% to 31%; and impact of communicable disease outbreaks and epidemics.
Responding to the needs of Women and Children in Yemen 301140
UK - Foreign, Commonwealth Development Office (FCDO)
This programme will address the devastating impact the conflict in Yemen is having on women and children, particularly the most marginalised. It will provide access to life-saving integrated health, nutrition, water, sanitation and hygiene (WASH) and protection services. This approach responds directly to two key UK humanitarian aims in Yemen: preventing famine and ensuring respect for International Humanitarian Law.
Health Resilience Fund in Zimbabwe 2021-2025
UK - Foreign, Commonwealth Development Office (FCDO)
To support a resilient health system in Zimbabwe that is equipped to deliver quality sexual, reproductive, maternal, newborn, child and adolescent health and nutrition services.
Scaling up Family Planning in Tanzania
UK - Foreign, Commonwealth Development Office (FCDO)
This is a national programme to scale up access to family planning across Tanzania. Specific activities will include: • Outreach work in rural and urban areas as well as in Tanzania’s refugee camps and host communities. • Specific work to improve access to family planning as well as sexual and reproductive health information to youth, people with disabilities as well as services for victims of sexual violence. • Procure family planning commodities, strengthen the supply chain, and train of public health providers
Better Lives for Somali Women and Children
UK - Foreign, Commonwealth Development Office (FCDO)
To achieve UK's manifesto commitment of reducing preventable deaths, the Better Lives for Somali Women and Children will continue to respond to the health and nutrition needs of the Somali people. There will be a continued focus on delivering an essential package of health services. The programme will strengthen the Somali Health Authorities oversight of service provision, which will in turn promote local accountability and allow them increasingly to respond to the needs of their populations. This programme approach aims to support long term sustainability and state building that is part of the wider strategic agenda. There will also be a climate change mitigation component (ICF) within the programme.
Central Asia Small Projects Programme
UK - Foreign, Commonwealth Development Office (FCDO)
This programme will provide the mechanism for embassies to develop small projects to further the aims of the Country Business Plans and develop learning to support wider programming initiatives, with the overall aim of supporting development in the region.
Tackling Deadly Diseases in Africa Programme 2
UK - Foreign, Commonwealth Development Office (FCDO)
The Tackling Deadly Diseases in Africa 2 (TDDAP 2) programme will help implement the UK’s vision for progress on health security in Africa. It will provide technical and financial support to build health security capacity in up to 5 selected countries, including middle ground powers, strengthen key regional bodies such as the Africa Centre for Disease Control and establish long-term partnerships between African, UK and global institutions. Outcomes; • Strengthened regional institutions to help build and improve global health security; • Improved national public health systems and functions with increased national ownership and leadership of outbreak responses; • Communities trained and provided with the knowledge and tools to identify risks and respond to outbreaks; • An emergency response/contingency mechanism to enable the UK to quickly respond to disease outbreaks and help prevent these from escalating to crisis; • Independent monitoring and evaluation component
The Evidence Fund - 300708
UK - Foreign, Commonwealth Development Office (FCDO)
The Evidence Fund procures and manages research and evaluations that primarily benefit ODA eligible countries. Most research and evaluations paid for by the Evidence Fund are country-specific, and all respond to requests for evidence to inform programme or policy decisions. Primarily serving research requests from HMG’s Embassies and High Commissions in ODA eligible countries, and from HMG policy and strategy teams, the Evidence Fund strengthens the evidence behind the UK’s priority international development investments and development diplomacy. The Evidence Fund also invests modest amounts of non-ODA, to strengthen the evidence behind wider UK foreign policy.
Tackling Maternal and Child Undernutrition Programme- Phase II
UK - Foreign, Commonwealth Development Office (FCDO)
To contribute towards improved health and nutrition status for children under two years measured primarily by a reduction in stunting by 2023.
Ethiopia Crises 2 Resilience (EC2R)
UK - Foreign, Commonwealth Development Office (FCDO)
The Ethiopia Crises to Resilience (EC2R) programme is aimed to alleviate the impact of the conflict and drought to the poorest Ethiopians. The programme tries to address urgent humanitarian needs while maintaining the delivery of essential services across the country.
International Finance Facility for Immunisation
UK - Foreign, Commonwealth Development Office (FCDO)
Reduce vaccine preventable diseases (VPDs) in poor countries in a sustainable way using innovative financing approach
Investing in Human Capital through Partnerships Beyond Aid in the Social Sectors Programme
UK - Foreign, Commonwealth Development Office (FCDO)
To improve governance and accountability in education, health and social protection sectors and contribute to policy and research which will inform interventions to improve equity and reduce poverty.
UK Vaccine Network (UKVN) - Innovate UK - Vaccines for Epidemic Diseases: Readiness for clinical development and regulatory submission competition
UK - Department of Health and Social Care (DHSC)
This is an Official Development Assistance (ODA) funded UKaid project from the Department of Health and Social Care (DHSC)’s UK Vaccine Network (UKVN) which supports the development of vaccines and vaccine technology for infectious diseases with the potential to cause an epidemic in low- and middle-income countries (LMICs), focusing on areas of market failure. UKVN has identified a range of human diseases with epidemic potential in LMICs for which the development of vaccines is a priority. UKVN collaborated with Innovate UK to run a Small Business Research Initiative (SBRI) competition to invest in vaccines and vaccine technologies to address the priority disease families identified by UKVN (including Disease X - a pandemic pathogen that has not yet been characterised). Proposals could address any part of the pre-clinical, non-clinical, manufacturing, or clinical pathway, within a one-year time frame, making technology ready to be progressed further along the developmental pathway. The projects built on work from previous Innovate competitions, including: Innovate Clinical Vaccine Development Competition 2018/2021, Innovate Pre-clinical Vaccine Development Competition 2017/2021 and the Innovate Vaccine Development Competition to develop research across vaccine development. This project was not put out to an open, competitive tender process because, as a non-departmental public body of the UK government, Innovate UK is uniquely positioned to manage research calls.
Global Antimicrobial Resistance Innovation Fund (GAMRIF) - Vaccine Innovation with the Bacterial Vaccinology Network (BactiVac)
UK - Department of Health and Social Care (DHSC)
This is an Official Development Assistance (ODA) funded UKaid project from the Department of Health and Social Care (DHSC)’s Global Antimicrobial Resistance Innovation Fund (GAMRIF). GAMRIF funds research and development to fight antimicrobial resistance (AMR) in low- and middle-income countries (LMICs) where the burden of drug-resistant infection is greater. This project is delivered in partnership with the Bacterial Vaccinology Network (BactiVac) to support the development of vaccines for antimicrobial resistance (AMR) in humans and animals. BactiVac is one of five networks that are supported by the Global Challenges Research Fund (GCRF) Networks in Vaccines Research and Development which is co-funded by the UK Medical Research Council (MRC) and the UK Biotechnology and Biological Sciences Research Council (BBSRC). The primary aim of this investment is to accelerate the development of vaccines against bacterial infections, so that antimicrobial use in humans and animals is reduced in LMICs. This investment also supports new, diverse research projects to gain preliminary data and encourage new research partnerships, and allow these collaborations to build a track record, which will allow them to obtain further funding. It is expected that some of these projects will not yield expected research results, yet the dissemination of both positive and negative research outcomes is valuable and expected. Funded projects will undertake early-stage research and development with catalyst pump-priming funding around the world to help drive the development and uptake of vaccines for AMR for the benefit of people in LMICs.
Global Antimicrobial Resistance Innovation Fund (GAMRIF) - Accelerating Antibacterial Innovation with Combating Antibiotic Resistant Bacteria Accelerator (CARB-X)
UK - Department of Health and Social Care (DHSC)
This is an Official Development Assistance (ODA) funded UKaid project from the Department of Health and Social Care (DHSC)’s Global Antimicrobial Resistance Innovation Fund (GAMRIF) which funds research and development to fight antimicrobial resistance (AMR) in low- and middle-income countries (LMICs) where the burden of drug-resistant infection is greater. This project is delivered in partnership with Boston University’s Combating Antibiotic Resistant Bacteria Accelerator (CARB-X), a non-profit, multi-donor international partnership that supports innovative early product research and development focused on the most dangerous drug-resistant bacteria. This partnership will invest in high-value, innovative research to accelerate the development of products to reduce the harm to human health, welfare and economic growth from drug-resistant infections, up to and including Phase I. The programme will focus on prevention (including vaccines) and alternatives to antibiotics for humans as primarily and directly relevant to people in LMICs.
Global Antimicrobial Resistance Innovation Fund (GAMRIF) - InnoVet AMR: Innovative Veterinary Solutions for Antimicrobial Resistance (AMR) with the International Development Research Centre (IDRC)
UK - Department of Health and Social Care (DHSC)
This is an Official Development Assistance (ODA) funded UKaid project from the Department of Health and Social Care (DHSC)’s Global Antimicrobial Resistance Innovation Fund (GAMRIF) which funds research and development to fight antimicrobial resistance (AMR) in low- and middle-income countries (LMICs) where the burden of drug-resistant infection is greater. This project is delivered in partnership with the International Development Research Centre (IDRC) and aims to reduce the emerging risk that antimicrobial resistance (AMR) in animals poses to global health and food security. InnoVet-AMR will fund research to develop new animal vaccines and other innovations to fight AMR in livestock (swine and poultry) and aquaculture production, particularly in LMICs. Through InnoVet-AMR, DHSC and IDRC aim to achieve two main objectives: (1) Support research that will identify innovative veterinary solutions, including vaccines and alternative solutions, to reduce the use of antimicrobials in livestock and aquaculture operations in LMICs; and (2) Build effective partnerships to better coordinate discovery, development and sustainable delivery of affordable innovative veterinary solutions to reduce the use of antimicrobials in livestock and aquaculture operations in LMICs. As part of the InnoVet-AMR programme, GAMRIF has also allocated additional funding to a partnership with the International Centre for Antimicrobial Resistance Solutions (ICARS). This complimentary research activity will support scoping and research projects focused on climate change, gender and equity in AMR mitigation.
Global Antimicrobial Resistance Innovation Fund (GAMRIF) - Innovation in Antimicrobial Resistance (AMR) Diagnostic Tools with the Foundation for Innovative New Diagnostics (FIND)
UK - Department of Health and Social Care (DHSC)
This is an Official Development Assistance (ODA) funded UKaid project from the Department of Health and Social Care (DHSC)’s Global Antimicrobial Resistance Innovation Fund (GAMRIF) which funds research and development to fight antimicrobial resistance (AMR) in low- and middle-income countries (LMICs) where the burden of drug-resistant infection is greater. The project is delivered in partnership with the Foundation for Innovative New Diagnostics (FIND), a global non-profit product development partnership that aims to develop, evaluate and deliver high-quality affordable diagnostic tests for poverty-related diseases. Funding through GAMRIF will support FIND’s work to enhance the impact of diagnostic tools for AMR, improving AMR surveillance and antibiotic stewardship. This work has two areas of focus: (1) To develop technological methods to connect data from patient testing and health provider consultations to larger data systems, such as national and international AMR surveillance programmes. This will lead to improved antibiotic use and AMR surveillance through increased access to data; and (2) To develop new diagnostic technologies for drug-resistant gonorrhoea, which will enable improved diagnosis and therefore use of new antibiotics.
Advanced filters
To search for Programmes in a specific time period, please enter the start and end dates.